Cytek Biosciences, Inc. CTKB Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s accounts receivable?
- Cytek Biosciences, Inc. (CTKB) reported accounts receivable of $51.9M in Q1 2026.
- How has Cytek Biosciences, Inc.'s accounts receivable changed year-over-year?
- Cytek Biosciences, Inc.'s accounts receivable decreased by 5.7% year-over-year, from $55.03M to $51.9M.
- What is the long-term trend for Cytek Biosciences, Inc.'s accounts receivable?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s accounts receivable has grown at a 29.9% compound annual growth rate (CAGR), from $81M to $230.4M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.